UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030472
Receipt number R000034796
Scientific Title Validation of predictive and prognostic markers in upper gastrointestinal cancer
Date of disclosure of the study information 2017/12/20
Last modified on 2022/10/19 09:44:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Validation of predictive and prognostic markers in upper gastrointestinal cancer

Acronym

Validation of predictive and prognostic markers

Scientific Title

Validation of predictive and prognostic markers in upper gastrointestinal cancer

Scientific Title:Acronym

Validation of predictive and prognostic markers

Region

Japan


Condition

Condition

Upper gastrointestinal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

In this study, we examine the utility of biomarkers as a predictor of survival in Upper gastrointestinal cancer

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Cancer-specific survival

Key secondary outcomes

Overall survival


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Histopathologically proven gastric cancer
2.20 years of age and older
90 yearrs of age and younger
3.ECOG performance status 0 or 1
4.No previous treatment (chemotherapy, radootherapy) for any cancer in recent 5 years
5.Patients who can take medecine orally

Key exclusion criteria

1.Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ or mucosal carcinoma, and multicentric cancer.
2.Patients with severe complication (intestinal paralysis, intestinal obstruction, interstitial pneumonitis, pulmonary fibrosis, severe diabetes, heart failure, renal failure, liver cirrhosis, liver failure, etc.).
3.Patients with infections.

Target sample size

800


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Noriyuki Hirahara

Organization

Shimane University Faculty of Medicine

Division name

Department of Digestive and General Surgery

Zip code


Address

89-1 Enya-cho, Izumo Shimane 693-8501

TEL

+81-853-20-2232

Email

norinori@med.shimane-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Noriyuki Hirahara

Organization

Shimane University Faculty of Medicine

Division name

Department of Digestive and General Surgery

Zip code


Address

89-1 Enya-cho, Izumo Shimane 693-8501

TEL

+81-853-20-2232

Homepage URL


Email

norinori@med.shimane-u.ac.jp


Sponsor or person

Institute

Shimane University Faculty of Medicine

Institute

Department

Personal name



Funding Source

Organization

Shimane University Faculty of Medicine

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2017 Year 12 Month 13 Day

Date of IRB

2017 Year 12 Month 13 Day

Anticipated trial start date

2017 Year 12 Month 20 Day

Last follow-up date

2029 Year 12 Month 31 Day

Date of closure to data entry

2029 Year 12 Month 31 Day

Date trial data considered complete

2029 Year 12 Month 31 Day

Date analysis concluded

2029 Year 12 Month 31 Day


Other

Other related information

No


Management information

Registered date

2017 Year 12 Month 19 Day

Last modified on

2022 Year 10 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034796


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name